Payment overview · 2025
General Payments
$131.65
6 reported records · 2 companies
Healthcare provider profile · identity verified
Fredickson Manuel Vargas, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SAN GERMAN, PR · NPI 1649248758
Verified facts
What the public records show
CMS Open Payments records show Fredickson Manuel Vargas, MD received $131.65 in general payments during 2025 across 6 reported records.
AstraZeneca Pharmaceuticals LP accounted for 78.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 250 claims for Farxiga by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $103.77 | 78.8% | 5 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $27.88 | 21.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $131.65 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $27.88 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $15.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 33 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
250 | 47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Losartan Potassium | Losartan Potassium | 1567 | 339 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1507 | 185 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1479 | 353 |
| Gabapentin | Gabapentin | 1415 | 216 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1012 | 155 |
| Metoprolol Succinate | Metoprolol Succinate | 878 | 177 |
| Metformin Hcl | Metformin Hcl | 849 | 181 |
| Glimepiride | Glimepiride | 690 | 134 |
| Furosemide | Furosemide | 664 | 117 |
| Alendronate Sodium | Alendronate Sodium | 646 | 106 |
| Simvastatin | Simvastatin | 622 | 155 |
| Clopidogrel | Clopidogrel Bisulfate | 618 | 115 |
| Amlodipine Besylate | Amlodipine Besylate | 594 | 114 |
| Synthroid | Levothyroxine Sodium | 518 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 460 | 95 |
| Lisinopril | Lisinopril | 438 | 108 |
| Metformin Hcl Er | Metformin Hcl | 402 | 80 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 368 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 359 | 81 |
| Sertraline Hcl | Sertraline Hcl | 356 | 64 |
| Carvedilol | Carvedilol | 345 | 70 |
| Finasteride | Finasteride | 338 | 57 |
| Trazodone Hcl | Trazodone Hcl | 319 | 58 |
| Clonazepam | Clonazepam | 296 | 38 |
| Doxazosin Mesylate | Doxazosin Mesylate | 289 | 50 |
| Prednisone | Prednisone | 254 | 99 |
| Farxiga | Dapagliflozin Propanediol | 250 | 47 |
| Meloxicam | Meloxicam | 250 | 131 |
| Famotidine | Famotidine | 249 | 83 |
| Montelukast Sodium | Montelukast Sodium | 249 | 45 |
| Irbesartan | Irbesartan | 238 | 41 |
| Pioglitazone Hcl | Pioglitazone Hcl | 238 | 42 |
| Allopurinol | Allopurinol | 232 | 43 |
| Atenolol | Atenolol | 227 | 48 |
| Omeprazole | Omeprazole | 218 | 57 |
| Tizanidine Hcl | Tizanidine Hcl | 190 | 117 |
| Methotrexate | Methotrexate Sodium | 188 | 27 |
| Memantine Hcl | Memantine Hcl | 187 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 173 | 26 |
| Warfarin Sodium | Warfarin Sodium | 170 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 162 | 38 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 159 | 30 |
| Eliquis | Apixaban | 144 | 25 |
| Alprazolam | Alprazolam | 140 | 18 |
| Azithromycin | Azithromycin | 140 | 113 |
| Verapamil Er | Verapamil Hcl | 140 | 31 |
| Nifedipine Er | Nifedipine | 139 | 21 |
| Spironolactone | Spironolactone | 138 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 136 | 20 |
| Dexamethasone | Dexamethasone | 136 | 105 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 133 | 61 |
| Glipizide | Glipizide | 120 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 117 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 116 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 113 | 16 |
| Fenofibrate | Fenofibrate | 107 | 29 |
| Cilostazol | Cilostazol | 106 | 20 |
| Donepezil Hcl | Donepezil Hcl | 106 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 106 | 24 |
| Valsartan | Valsartan | 104 | 16 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 102 | 19 |
| Temazepam | Temazepam | 96 | 16 |
| Levofloxacin | Levofloxacin | 95 | 78 |
| Digoxin | Digoxin | 94 | 15 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 92 | 16 |
| Mirtazapine | Mirtazapine | 91 | 14 |
| Humulin N | Insulin Nph Human Isophane | 87 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 36 |
| Latanoprost | Latanoprost | 75 | 13 |
| Buspirone Hcl | Buspirone Hcl | 70 | 11 |
| Bumetanide | Bumetanide | 68 | 16 |
| Risperidone | Risperidone | 68 | 11 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 63 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 17 |
| Xarelto | Rivaroxaban | 56 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 55 | suppressed |
| Pregabalin | Pregabalin | 54 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 53 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 52 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 51 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 52 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 50 | 31 |
| Humulin R | Insulin Regular, Human | 50 | 11 |
| Diclofenac Potassium | Diclofenac Potassium | 49 | 31 |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | suppressed |
| Levetiracetam | Levetiracetam | 46 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 43 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 34 |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 38 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 38 | suppressed |
| Levoxyl | Levothyroxine Sodium | 37 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 36 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 35 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Galantamine Er | Galantamine Hbr | 33 | suppressed |
| Jardiance | Empagliflozin | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | 15 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 30 | 18 |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 30 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 29 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 28 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Lorazepam | Lorazepam | 28 | suppressed |
| Methimazole | Methimazole | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 27 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 26 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 26 | suppressed |
| Cephalexin | Cephalexin | 25 | 24 |
| Clobetasol Propionate | Clobetasol Propionate | 25 | 16 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 25 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Levo-T | Levothyroxine Sodium | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | 23 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 21 | 11 |
| Pentoxifylline | Pentoxifylline | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 20 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | 18 |
| Insulin Lispro | Insulin Lispro | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Nabumetone | Nabumetone | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 19 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 16 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Cefadroxil | Cefadroxil | 16 | 15 |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 13 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Verapamil Sr | Verapamil Hcl | 15 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 14 | 14 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | 11 |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 13 | 13 |
| Sulfasalazine | Sulfasalazine | 13 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 12 | suppressed |
| Bicillin L-A | Penicillin G Benzathine | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | 11 |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $131.65 · 6 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, JARDIANCE | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error